Literature DB >> 19430088

Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?

Nadia Warner1, Stephen Locarnini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19430088

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


× No keyword cloud information.
  3 in total

Review 1.  Progression and status of antiviral monitoring in patients with chronic hepatitis B: From HBsAg to HBV RNA.

Authors:  Ya-Yun Liu; Xue-Song Liang
Journal:  World J Hepatol       Date:  2018-09-27

2.  Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection.

Authors:  Yayun Liu; Meng Jiang; Jianya Xue; Hongli Yan; Xuesong Liang
Journal:  BMC Gastroenterol       Date:  2019-04-16       Impact factor: 3.067

3.  Mutational analysis of reverse transcriptase and surface proteins of patients with partial virological response during mono and combination antiviral therapies in genotype D chronic hepatitis B.

Authors:  Mostafa Mahabadi; Seyed Moayed Alavian; Mehdi Norouzi; Hossein Keyvani; Mahmood Mahmoudi; Seyed Mohammad Jazayeri
Journal:  Electron Physician       Date:  2016-06-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.